Literature DB >> 11259171

Three genes with different functions in transformation are regulated by c-Myb in myeloid cells.

L Wolff1, M Schmidt, R Koller, P Haviernik, R Watson, J Bies, K Maciag.   

Abstract

The proto-oncogene c-myb is constitutively expressed in murine leukemia virus-induced myeloid leukemia (MML) due to the integration of virus at this locus. Our recent focus has been the determination of genes regulated by this transcription factor that may be involved in transformation. Data presented here, using conditional expression of Myb in myeloid cells, show that c-Myb directly transactivates the endogenous c-myc and Bcl-2 genes, which explains at least in part how c-Myb regulates proliferation and survival. In addition, c-Myb prevents expression at the RNA level of the tumor suppressor INK4b gene. This gene encodes a cyclin-dependent kinase inhibitor, p15INK4b, that is normally upregulated at the mRNA level during myeloid differentiation and promotes growth arrest. The MMLs are generally characterized as differentiated monocytic tumors and possess the phenotype that is normally associated with p15INK4b expression. c-Myb inhibits expression of this gene, however, and therefore acts to promote a pathway which is abnormal in mature cells. This activity of c-Myb collaborates with its maintenance of c-myc expression to promote growth. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11259171     DOI: 10.1006/bcmd.2001.0409

Source DB:  PubMed          Journal:  Blood Cells Mol Dis        ISSN: 1079-9796            Impact factor:   3.039


  11 in total

1.  B-myb and C-myb play required roles in neuronal apoptosis evoked by nerve growth factor deprivation and DNA damage.

Authors:  David X Liu; Subhas C Biswas; Lloyd A Greene
Journal:  J Neurosci       Date:  2004-10-06       Impact factor: 6.167

2.  Impaired adult myeloid progenitor CMP and GMP cell function in conditional c-myb-knockout mice.

Authors:  Yen K Lieu; E Premkumar Reddy
Journal:  Cell Cycle       Date:  2012-08-23       Impact factor: 4.534

3.  Sox4 cooperates with CREB in myeloid transformation.

Authors:  Salemiz Sandoval; Christina Kraus; Er-Chieh Cho; Michelle Cho; Juraj Bies; Elena Manara; Benedetta Accordi; Elliot M Landaw; Linda Wolff; Martina Pigazzi; Kathleen M Sakamoto
Journal:  Blood       Date:  2012-05-24       Impact factor: 22.113

4.  Estrogen prevents sustained COLO-205 human colon cancer cell growth by inducing apoptosis, decreasing c-myb protein, and decreasing transcription of the anti-apoptotic protein bcl-2.

Authors:  Heather R Wilkins; Kristin Doucet; Victoria Duke; Amber Morra; Nicole Johnson
Journal:  Tumour Biol       Date:  2009-12-18

5.  MiR-148a promotes apoptosis by targeting Bcl-2 in colorectal cancer.

Authors:  H Zhang; Y Li; Q Huang; X Ren; H Hu; H Sheng; M Lai
Journal:  Cell Death Differ       Date:  2011-04-01       Impact factor: 15.828

6.  Human T-cell lymphotropic virus type 1 Tax represses c-Myb-dependent transcription through activation of the NF-kappaB pathway and modulation of coactivator usage.

Authors:  C Nicot; R Mahieux; C Pise-Masison; J Brady; A Gessain; S Yamaoka; G Franchini
Journal:  Mol Cell Biol       Date:  2001-11       Impact factor: 4.272

7.  A degradation-resistant c-Myb mutant cooperates with Bcl-2 in enhancing proliferative potential and survival of hematopoietic cells.

Authors:  Francesca Corradini; Rita Bussolari; Davide Cerioli; Maria Rosa Lidonnici; Bruno Calabretta
Journal:  Blood Cells Mol Dis       Date:  2007-07-23       Impact factor: 3.039

8.  Myb expression is critical for myeloid leukemia development induced by Setbp1 activation.

Authors:  Nhu Nguyen; Bandana A Vishwakarma; Kevin Oakley; Yufen Han; Bartlomiej Przychodzen; Jaroslaw P Maciejewski; Yang Du
Journal:  Oncotarget       Date:  2016-12-27

Review 9.  SETBP1 dysregulation in congenital disorders and myeloid neoplasms.

Authors:  Nicoletta Coccaro; Giuseppina Tota; Antonella Zagaria; Luisa Anelli; Giorgina Specchia; Francesco Albano
Journal:  Oncotarget       Date:  2017-04-19

10.  BCR-ABL1 mediated miR-150 downregulation through MYC contributed to myeloid differentiation block and drug resistance in chronic myeloid leukemia.

Authors:  Klara Srutova; Nikola Curik; Pavel Burda; Filipp Savvulidi; Giovannino Silvestri; Rossana Trotta; Hana Klamova; Pavla Pecherkova; Zofie Sovova; Jitka Koblihova; Tomas Stopka; Danilo Perrotti; Katerina Machova Polakova
Journal:  Haematologica       Date:  2018-07-26       Impact factor: 9.941

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.